-
T106193-5gL-Thyroxine, free acid, L-Thyroxine (T4) and triiodo-L-thyronine (T3) are hormones containing iron produced from thyroglobulin in the follicular cells of the thyroid. The stimulation of growth and development and regulation of metabolic rate by
-
L649937-10mgL-Tyrosine-d 5 is the deuterium labeled L-Tyrosine. L-Tyrosine is a non-essential amino acid which can inhibit citrate synthase activity in the posterior cortex.In VitroStable heavy isotopes of hydrogen, carbon, and other elements have been
-
L649937-1mgL-Tyrosine-d 5 is the deuterium labeled L-Tyrosine. L-Tyrosine is a non-essential amino acid which can inhibit citrate synthase activity in the posterior cortex.In VitroStable heavy isotopes of hydrogen, carbon, and other elements have been
-
L649937-5mgL-Tyrosine-d 5 is the deuterium labeled L-Tyrosine. L-Tyrosine is a non-essential amino acid which can inhibit citrate synthase activity in the posterior cortex.In VitroStable heavy isotopes of hydrogen, carbon, and other elements have been
-
L130208-10mgLanosterol, an amphipathic molecule, that is produced by lanosterol synthase (LSS). It is enriched in the lens.
-
L130208-1mgLanosterol, an amphipathic molecule, that is produced by lanosterol synthase (LSS). It is enriched in the lens.
-
L130208-25mgLanosterol, an amphipathic molecule, that is produced by lanosterol synthase (LSS). It is enriched in the lens.
-
L130208-50mgLanosterol, an amphipathic molecule, that is produced by lanosterol synthase (LSS). It is enriched in the lens.
-
L130208-5mgLanosterol, an amphipathic molecule, that is produced by lanosterol synthase (LSS). It is enriched in the lens.
-
L126696-100mgLapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively.An antineoplastic agent used in breast cancer research.
-
L126696-1gLapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively.An antineoplastic agent used in breast cancer research.
-
L126696-250mgLapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively.An antineoplastic agent used in breast cancer research.